Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Piotroski F-Score: 2 (As of Jul. 20, 2026) — 33% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:ONCO3 Oncoclinicas Do Brasil Servicos Medicos SA BSP:ONCO3
46 GF Score
Price R$0.78
GF Value R$3.47
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Oncoclinicas Do Brasil Servicos Medicos Piotroski F-Score?

Oncoclinicas Do Brasil Servicos Medicos BSP:ONCO3 -8.24% 46 Piotroski F-Score is 2 as of Jul. 20, 2026, which is 33% below its 10-year median of 3.00. GuruFocus rates BSP:ONCO3 with a GF Score™ of 46/100 and a GF Value™ of R$3.47 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 646 Healthcare Providers & Services companies, Oncoclinicas Do Brasil Servicos Medicos ranks worse than 92.88% on this metric.

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Oncoclinicas Do Brasil Servicos Medicos has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Oncoclinicas Do Brasil Servicos Medicos's Piotroski F-Score or its related term are showing as below:

BSP:ONCO3' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 7
Current: 2

During the past 8 years, the highest Piotroski F-Score of Oncoclinicas Do Brasil Servicos Medicos was 7. The lowest was 2. And the median was 3.

Oncoclinicas Do Brasil Servicos Medicos  (BSP:ONCO3) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Oncoclinicas Do Brasil Servicos Medicos Piotroski F-Score Related Terms


Oncoclinicas Do Brasil Servicos Medicos Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Oncoclinicas Do Brasil Servicos Medicos's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncoclinicas Do Brasil Servicos Medicos Piotroski F-Score Chart

Oncoclinicas Do Brasil Servicos Medicos Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial 5.00 4.00 4.00 4.00 2.00

Oncoclinicas Do Brasil Servicos Medicos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 2.00 2.00 2.00 2.00

BSP:ONCO3 vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Oncoclinicas Do Brasil Servicos Medicos's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncoclinicas Do Brasil Servicos Medicos Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oncoclinicas Do Brasil Servicos Medicos's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Oncoclinicas Do Brasil Servicos Medicos's Piotroski F-Score falls into.


BSP:ONCO3
46GF Score
Oncoclinicas Do Brasil Servicos Medicos SA BSP:ONCO3
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -140.992 + -1882.321 + -1453.981 + -364.204 = R$-3,841 Mil.
Cash Flow from Operations was -449.529 + 151.754 + 256.013 + -219.039 = R$-261 Mil.
Revenue was 1464.389 + 1412.993 + 1368.829 + 1160.771 = R$5,407 Mil.
Gross Profit was 440.007 + 453.139 + 480.911 + 199.45 = R$1,574 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(10825.812 + 10301.343 + 8221.357 + 7130.514 + 6699.638) / 5 = R$8635.7328 Mil.
Total Assets at the begining of this year (Mar25) was R$10,826 Mil.
Long-Term Debt & Capital Lease Obligation was R$458 Mil.
Total Current Assets was R$2,470 Mil.
Total Current Liabilities was R$5,350 Mil.
Net Income was 3.302 + -15.94 + -643.144 + -146.494 = R$-802 Mil.

Revenue was 1567.63 + 1634.891 + 1566.04 + 1493.156 = R$6,262 Mil.
Gross Profit was 526.968 + 548.092 + 503.078 + 412.244 = R$1,990 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(9765.882 + 12105.38 + 12267.955 + 11202.332 + 10825.812) / 5 = R$11233.4722 Mil.
Total Assets at the begining of last year (Mar24) was R$9,766 Mil.
Long-Term Debt & Capital Lease Obligation was R$4,673 Mil.
Total Current Assets was R$4,203 Mil.
Total Current Liabilities was R$2,328 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Oncoclinicas Do Brasil Servicos Medicos's current Net Income (TTM) was -3,841. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Oncoclinicas Do Brasil Servicos Medicos's current Cash Flow from Operations (TTM) was -261. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-3841.498/10825.812
=-0.35484618

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-802.276/9765.882
=-0.0821509

Oncoclinicas Do Brasil Servicos Medicos's return on assets of this year was -0.35484618. Oncoclinicas Do Brasil Servicos Medicos's return on assets of last year was -0.0821509. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Oncoclinicas Do Brasil Servicos Medicos's current Net Income (TTM) was -3,841. Oncoclinicas Do Brasil Servicos Medicos's current Cash Flow from Operations (TTM) was -261. ==> -261 > -3,841 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=457.989/8635.7328
=0.05303418

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=4673.304/11233.4722
=0.41601598

Oncoclinicas Do Brasil Servicos Medicos's gearing of this year was 0.05303418. Oncoclinicas Do Brasil Servicos Medicos's gearing of last year was 0.41601598. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=2469.726/5350.118
=0.46162085

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=4202.724/2327.665
=1.80555363

Oncoclinicas Do Brasil Servicos Medicos's current ratio of this year was 0.46162085. Oncoclinicas Do Brasil Servicos Medicos's current ratio of last year was 1.80555363. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Oncoclinicas Do Brasil Servicos Medicos's number of shares in issue this year was 881.305. Oncoclinicas Do Brasil Servicos Medicos's number of shares in issue last year was 597.377. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1573.507/5406.982
=0.29101391

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1990.382/6261.717
=0.31786521

Oncoclinicas Do Brasil Servicos Medicos's gross margin of this year was 0.29101391. Oncoclinicas Do Brasil Servicos Medicos's gross margin of last year was 0.31786521. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=5406.982/10825.812
=0.49945279

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=6261.717/9765.882
=0.64118295

Oncoclinicas Do Brasil Servicos Medicos's asset turnover of this year was 0.49945279. Oncoclinicas Do Brasil Servicos Medicos's asset turnover of last year was 0.64118295. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Oncoclinicas Do Brasil Servicos Medicos has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 2 mean?
Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) has a Piotroski F-Score of 2 as of Jul. 20, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Oncoclinicas Do Brasil Servicos Medicos and its competitors. This is 33% below median its historical median of 3.00. Over the past decade, Oncoclinicas Do Brasil Servicos Medicos' Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #600 out of 646 companies in the Healthcare Providers & Services industry, placing it in the top 92.9%.
Is Oncoclinicas Do Brasil Servicos Medicos' Piotroski F-Score too high?
Oncoclinicas Do Brasil Servicos Medicos' current Piotroski F-Score of 2 is 33% below median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Oncoclinicas Do Brasil Servicos Medicos' value of 2 is 60% below this industry median. Based on the distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #600 out of 646 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oncoclinicas Do Brasil Servicos Medicos has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oncoclinicas Do Brasil Servicos Medicos' Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #600 out of 646 companies for Piotroski F-Score. This places Oncoclinicas Do Brasil Servicos Medicos in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Oncoclinicas Do Brasil Servicos Medicos' value of 2 is 60% below this benchmark. Historically, Oncoclinicas Do Brasil Servicos Medicos' own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 5.00, Oncoclinicas Do Brasil Servicos Medicos has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oncoclinicas Do Brasil Servicos Medicos's current Piotroski F-Score of 2 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Oncoclinicas Do Brasil Servicos Medicos and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncoclinicas Do Brasil Servicos Medicos's current Piotroski F-Score is 2, which is 33% below median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoclinicas Do Brasil Servicos Medicos stock overvalued right now?
Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$3.47, compared to a current price of R$0.78 — trading 77.5% below its estimated fair value. The current Piotroski F-Score is 2, which is 33% below median its 10-year median of 3.00 and 60% below the Healthcare Providers & Services industry median of 5.00. Oncoclinicas Do Brasil Servicos Medicos' overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3), the current Piotroski F-Score is 2 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Overvalued in 2026?

Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos stock appears to be undervalued. The current stock price of R$0.78 is trading 77.5% below its estimated GF Value™ of R$3.47. GuruFocus considers Oncoclinicas Do Brasil Servicos Medicos to be Possible Value Trap.

Key valuation signals for BSP:ONCO3:

  • Piotroski F-Score: 2 (33% below median its 10-year median of 3.00)
  • GF Value™: R$3.47 vs. price of R$0.78 (77.5% below fair value)
  • GF Score™: 46/100 with 6 warning signs
  • Industry Position: 60% below the Healthcare Providers & Services median (#600 of 646)

No single metric tells the full story. See the BSP:ONCO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oncoclinicas Do Brasil Servicos Medicos Business Description

Address Avenida Presidente Juscelino Kubitschek, No. 510, 2nd Floor, Vila Nova Conceicao, Sao Paulo, SP, BRA, 04543-906
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology, and bone marrow transplantation, complementary care. The Group operates solely in the healthcare services segment, with an emphasis on oncology.
46GF Score

Get the complete analysis for BSP:ONCO3

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$0.78
Price
R$3.47
GF Value